Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion type Assertion NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_head.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_provenance.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion evidence source_evidence_literature NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_provenance.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion SIO_000772 14500350 NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_provenance.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion wasDerivedFrom befree-2016 NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_provenance.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion wasGeneratedBy ECO_0000203 NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_provenance.